• news.cision.com/
  • aXichem AB/
  • aXichem Applies for Feed Additive Approval in the EU for the Company’s Unique Feed Ingredient aXiphen feed

aXichem Applies for Feed Additive Approval in the EU for the Company’s Unique Feed Ingredient aXiphen feed

Report this content

aXichem AB (publ), a developer of natural analogue industrial compounds, announces that the company applies for Feed Additive approval in the EU for its unique and innovative feed ingredient product aXiphen. The Feed Additives Regulation managed by the European Food Safety Autohrity (EFSA) establishes a common procedure for authorizing feed additives and lays down rules for their placing on the market, labelling and use in the European Union.

“In line with our communicated plan we are now applying for a Feed Additive approval from EFSA, with the aim to get the certificate before the year’s end. The Novel Food directive has served us well also for feed trials during the initial phase of the establishment of aXiphen feed, and will continue to do so, but as we now aim for larger volumes, targeting leading feed producers, Feed Additive is required. I feel confident that we have high quality data in the filed material which should mean that we have a solid platform for a good process forward,“ says Torsten Helsing, CEO of aXichem.

About aXiphen®
aXiphen is a natural analogue substance, a synthetically produced and patented capsaicin, based on a molecule developed by aXichem. Since aXiphen is synthetically produced the substance has several advantages compared to natural capsaicin. The main difference is that natural capsaicin is extracted from chili and therefore varies in quality and seldom reaches a concentration above 85 percent. aXiphen holds a concentration of at least 97 percent and has predictable characteristics. One of the key industrial benefits of aXiphen is that aXichem can determine its water- and fat solubility, which is critical when using the substance in various kinds of products.

This information is such that aXichem AB (publ) is obliged to publish in accordance with the EU Market Abuse Regulation. The information was submitted, through the care of the contact person, for publication on March 31, 2022, at 05:35 PM CEST.

Torsten Helsing, CEO, aXichem, Ph+46 70 686 33 55. Email: torsten.helsing@axichem.se

aXichems affärsidé är att utveckla, patentera och marknadsföra naturanaloga industrikemikalier. Bolaget arbetar framför allt med fenylcapsaicin, en naturanalog syntetisk capsaicin med breda tillämpningar inom en mängd olika områden, såsom kosttillskott, ingrediens i djurfoder, marina tillämpningar samt enskilda farmaceutiska områden. aXichems aktie är listad på NASDAQ First North Growth Market med kortnamnet AXIC A. Certified Adviser: Redeye AB Certifiedadviser@redeye.se +46 (0)8 121 576 90. Mer information om bolaget finns påwww.axichem.se

Taggar:

Prenumerera

Citat

In line with our communicated plan we are now applying for a Feed Additive approval from EFSA, with the aim to get the certificate before the year’s end.
Torsten Helsing, CEO, aXichem